Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes

被引:6
作者
Han, Bing [1 ]
Shi, Xiao-Lei [1 ]
Xiao, Jiang-Qiang [1 ]
Zhang, Yue [2 ]
Chu, Xue-Hui [1 ]
Gu, Jin-Yang [1 ]
Tan, Jia-Jun [1 ]
Gu, Zhong-Ze [3 ]
Ding, Yi-Tao [1 ,2 ]
机构
[1] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Hepatobiliary Surg, Nanjing 210008, Jiangsu Prov, Peoples R China
[2] Nanjing Med Univ, Drum Tower Clin Med Coll, Dept Hepatobiliary Surg, Nanjing 210008, Jiangsu Prov, Peoples R China
[3] Southeast Univ, State Key Lab Bioelect, Nanjing 210000, Jiangsu Prov, Peoples R China
关键词
Chitosan nanofiber scaffold; Porcine hepatocyte; Porcine endogenous retrovirus; Bioartificial liver; BIOARTIFICIAL LIVER SYSTEMS; CELLS IN-VITRO; PRODUCTIVE INFECTION; ENDOTHELIAL-CELLS; SUPPORT-SYSTEM; FAILURE; PERV; XENOTRANSPLANTATION; ESTABLISHMENT; TRANSMISSION;
D O I
10.3748/wjg.v17.i22.2774
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the influence of chitosan nanofiber scaffold on the production and infectivity of porcine endogenous retrovirus (PERV) expressed by porcine hepatocytes. METHODS: Freshly isolated porcine hepatocytes were cultured with or without chitosan nanofiber scaffold (defined as Nano group and Hep group) for 7 d. The daily collection of culture medium was used to detect reverse transcriptase (RT) activity with RT activity assay kits and PERV RNA by reverse transcription-polymerase chain reaction (PCR) and real time PCR with the PERV specific primers. And Western blotting was performed with the lysates of daily retrieved cells to determine the PERV protein gag p30. Besides, the in-vitro infectivity of the supernatant was tested by incubating the human embryo kidney 293 (HEK293) cells. RESULTS: The similar changing trends between two groups were observed in real time PCR, RT activity assay and Western blotting. Two peaks of PERV expression at 10H and Day 2 were found and followed by a regular decline. No significant difference was found between two groups except the significantly high level of PERV RNA at Day 6 and PERV protein at Day 5 in Nano group than that in Hep group. And in the in-vitro infection experiment, no HEK293 cell was infected by the supernatant. CONCLUSION: Chitosan nanofiber scaffold might prolong the PERV secreting time in pig hepatocytes but would not obviously influence its productive amount and infectivity, so it could be applied in the bioartificial liver without the increased risk of the virus transmission. (C) 2011 Baishideng. All rights reserved.
引用
收藏
页码:2774 / 2780
页数:7
相关论文
共 35 条
[1]   C-TYPE VIRUS PARTICLES IN PIG KIDNEY CELL LINES [J].
ARMSTRONG, JA ;
PORTERFIELD, JS ;
DEMADRID, AT .
JOURNAL OF GENERAL VIROLOGY, 1971, 10 (FEB) :195-+
[2]   Which are the right cells to be used in a bioartificial liver? [J].
Chamuleau, RAFM ;
Deurholt, T ;
Hoekstra, R .
METABOLIC BRAIN DISEASE, 2005, 20 (04) :327-335
[3]   In vitro evaluation of a multi-layer radial-flow bioreactor based on galactosylated chitosan nanofiber scaffolds [J].
Chu, Xue-Hui ;
Shi, Xiao-Lei ;
Feng, Zhang-Qi ;
Gu, Jin-Yang ;
Xu, Hai-Yun ;
Zhang, Yue ;
Gu, Zhong-Ze ;
Ding, Yi-Tao .
BIOMATERIALS, 2009, 30 (27) :4533-4538
[4]   Chitosan nanofiber scaffold enhances hepatocyte adhesion and function [J].
Chu, Xue-Hui ;
Shi, Xiao-Lei ;
Feng, Zhang-Qi ;
Gu, Zhong-Ze ;
Ding, Yi-Tao .
BIOTECHNOLOGY LETTERS, 2009, 31 (03) :347-352
[5]   Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells [J].
Czauderna, F ;
Fischer, N ;
Boller, K ;
Kurth, R ;
Tönjes, RR .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4028-4038
[6]   No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver [J].
Di Nicuolo, G ;
van de Kerkhove, MP ;
Hoekstra, R ;
Beld, MGHM ;
Amoroso, P ;
Battisti, S ;
Starace, M ;
di Florio, E ;
Scuderi, V ;
Scala, S ;
Bracco, A ;
Mancini, A ;
Chamuleau, RAFM ;
Calise, F .
XENOTRANSPLANTATION, 2005, 12 (04) :286-292
[7]   Hepatic tissue engineering: from transplantation to customized cell-based liver directed therapies from the laboratory [J].
Fiegel, Henning C. ;
Kaufmann, Peter M. ;
Bruns, Helge ;
Kluth, Dietrich ;
Horch, Raymund E. ;
Vacanti, Joseph P. ;
Kneser, Ulrich .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (01) :56-66
[8]   Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells [J].
Fruehauf, Jan-Henning ;
Mertsching, Heike ;
Giri, Shibashish ;
Fruehauf, Nils Roman ;
Bader, Augustinus .
LIVER INTERNATIONAL, 2009, 29 (10) :1553-1561
[9]   Design and validation of immunological tests for the detection of Porcine endogenous retrovirus in biological materials [J].
Galbraith, DN ;
Kelly, HT ;
Dyke, A ;
Reid, G ;
Haworth, C ;
Beekman, J ;
Shepherd, A ;
Smith, KT .
JOURNAL OF VIROLOGICAL METHODS, 2000, 90 (02) :115-124
[10]   Bioartificial liver systems: why, what, whither? [J].
Gerlach, Joerg C. ;
Zedinger, Katrin ;
Patzer, John F., II .
REGENERATIVE MEDICINE, 2008, 3 (04) :575-595